2 Minute Medicine Rewind September 7, 2020
Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome 1. There does not appear to be any ...
Tag: ACS
The ODYSSEY OUTCOMES trial: Alirocumab associated with reduced ischemic events after acute coronary syndrome
1. Among patients that suffered a recent acute coronary syndrome (ACS) and had elevated levels of atherogenic lipoproteins despite intensive ...
Atorvastatin loading before percutaneous coronary intervention improves outcomes in patients with acute coronary syndrome
1. In this prespecified secondary analysis of a randomized controlled trial, patients with acute coronary syndrome (ACS) who received a ...
Early invasive strategy associated with reduced cardiac death after acute coronary syndrome
1. From a cohort study of Danish patients presenting with acute coronary syndrome, early invasive revascularization interventions were associated with ...
Percutaneous intervention outcomes for STEMI similar for women and men
1. This meta-analysis of outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI) showed that women fared ...
![Combo angiotensin-neprilysin inhibitor superior to enalapril in heart failure [PARADIGM-HF trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Angiotensin-350x250.jpg)
2 Minute Medicine Rewind September 8 – September 14, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Angiotensin–Neprilysin ...
Computer more accurate than clinical gestalt in predicting ACS
Image: PD 1. In a low-risk population, a computerized attribute matching program predicted acute coronary syndrome (ACS) but not ;ulmonary ...
